Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Ultragreen AiFRA:U5T -4.59%31 Return-on-Tangible-Asset is 27.66% as of Jun. 2026, which is 41% below its 10-year median of 46.61. GuruFocus rates FRA:U5T with a GF Score™ of 31/100. The stock has 1 warning sign investors should review. Among 681 Healthcare Providers & Services companies, Ultragreen Ai ranks better than 98.83% on this metric.
Return-on-Tangible-Asset is calculated as Net Income divided by its average total tangible assets. Total tangible assets equals to Total Assets minus Intangible Assets. Ultragreen Ai's annualizedNet Income for the quarter that ended in Jun. 2026 was €68.1 Mil. Ultragreen Ai's average total tangible assets for the quarter that ended in Jun. 2026 was €246.3 Mil. Therefore, Ultragreen Ai's annualized Return-on-Tangible-Asset for the quarter that ended in Jun. 2026 was 27.66%.
The historical rank and industry rank for Ultragreen Ai's Return-on-Tangible-Asset or its related term are showing as below:
FRA:U5T'
s Return-on-Tangible-Asset Range Over the Past 10 Years
Min: 40.19 Med: 46.61 Max: 70.5
Current: 40.19
During the past 4 years, Ultragreen Ai's highest Return-on-Tangible-Asset was 70.50%. The lowest was 40.19%. And the median was 46.61%.
FRA:U5T's Return-on-Tangible-Asset is ranked better than 98.83% of 681
companies
in the Healthcare Providers & Services industry
Industry Median: 2.59
vs FRA:U5T: 40.19
Ultragreen Ai (FRA:U5T) Return-on-Tangible-Asset Explanation
Return-on-Tangible-Asset measures the rate of return on the average total tangible assets (total assets minus intangible assets). Tangible means physical in nature. Intangible Assets are assets that are not physical in nature, and typically "derive their value from legal or intellectual rights." Return-on-Tangible-Asset measures a firm's efficiency at generating profits from its tangible assets. It shows how well a company uses what it has to generate earnings. Return-on-Tangible-Assets can vary drastically across industries. Therefore, Return-on-Tangible-Asset should not be used to compare companies in different industries.
Be Aware
Like ROE and ROA, Return-on-Tangible-Asset is calculated with only 12 months data. Fluctuations in the companys earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective. Return-on-Tangible-Asset can be affected by events such as stock buyback or issuance, and by a companys tax rate and its interest payment. Return-on-Tangible-Asset may not reflect the true earning power of the assets. A more accurate measurement is ROC % (ROC).
Many analysts argue the higher return the better. Buffett states that really high Return-on-Tangible-Asset may indicate vulnerability in the durability of the competitive advantage.
Ultragreen Ai Return-on-Tangible-Asset Related Terms
Ultragreen Ai Return-on-Tangible-Asset Historical Data
* Premium members only.
The historical data trend for Ultragreen Ai's Return-on-Tangible-Asset can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
FRA:U5T vs VEEV, BTSG, HQY: Return-on-Tangible-Asset Comparison
For the Health Information Services subindustry, Ultragreen Ai's Return-on-Tangible-Asset, along with its competitors' market caps and Return-on-Tangible-Asset data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Ultragreen Ai Return-on-Tangible-Asset vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Ultragreen Ai's Return-on-Tangible-Asset distribution charts can be found below:
* The bar in red indicates where Ultragreen Ai's Return-on-Tangible-Asset falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Return-on-Tangible-Asset, the net income of the last fiscal year and the average total tangible assets over the fiscal year are used. In calculating the quarterly data,
the Net Income data used here is two times the semi-annual (Jun. 2026) net income data.
What does a Return-on-Tangible-Asset of 27.66% mean?
Ultragreen Ai (FRA:U5T) has a Return-on-Tangible-Asset of 27.66% as of Jun. 2026. Return on tangible assets is the ratio of current-period net income to average two-period tangible assets. View historical data on Ultragreen Ai and its competitors. This is 41% below median its historical median of 46.61. Over the past decade, Ultragreen Ai's Return-on-Tangible-Asset has ranged from 40.19 to 70.50. According to the industry distribution chart, Ultragreen Ai ranks #8 out of 681 companies in the Healthcare Providers & Services industry, placing it in the top 1.2%.
Is Ultragreen Ai's Return-on-Tangible-Asset too high?
Ultragreen Ai's current Return-on-Tangible-Asset of 27.66% is 41% below median its 10-year median of 46.61. Over the past 10 years, this metric has ranged from a low of 40.19 to a high of 70.50. The Healthcare Providers & Services industry median Return-on-Tangible-Asset is 2.59. Ultragreen Ai's value of 27.66% is 968% above this industry median. Based on the distribution chart, Ultragreen Ai ranks #8 out of 681 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Ultragreen Ai has a GF Score™ of 31/100, reflecting its overall financial health beyond just this single metric.
How does Ultragreen Ai's Return-on-Tangible-Asset compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, Ultragreen Ai ranks #8 out of 681 companies for Return-on-Tangible-Asset. This places Ultragreen Ai in the top 1% of its industry — outperforming the majority of peers. The industry median Return-on-Tangible-Asset is 2.59. Ultragreen Ai's value of 27.66% is 968% above this benchmark. Historically, Ultragreen Ai's own Return-on-Tangible-Asset has ranged from 40.19 to 70.50 over the past decade. While the company's 10-year median is 46.61 vs. the industry median of 2.59, Ultragreen Ai has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Return-on-Tangible-Asset for a Healthcare Providers & Services company?
The median Return-on-Tangible-Asset among Healthcare Providers & Services companies is 2.59, based on 681 companies in the industry. Companies in the top quartile (top 25%) have a Return-on-Tangible-Asset significantly above this median, while those in the bottom quartile fall well below. However, Return-on-Tangible-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Ultragreen Ai's current Return-on-Tangible-Asset of 27.66% is 968% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Return-on-Tangible-Asset mean?
A high Return-on-Tangible-Asset can signal that a stock is expensive relative to its fundamentals. Return on tangible assets is the ratio of current-period net income to average two-period tangible assets. View historical data on Ultragreen Ai and its competitors. For the Healthcare Providers & Services industry, the median Return-on-Tangible-Asset is 2.59 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Ultragreen Ai's current Return-on-Tangible-Asset is 27.66%, which is 41% below median its own 10-year median of 46.61. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ultragreen Ai stock overvalued right now?
Ultragreen Ai (FRA:U5T) has a current Return-on-Tangible-Asset of 27.66%. The current Return-on-Tangible-Asset is 27.66%, which is 41% below median its 10-year median of 46.61 and 968% above the Healthcare Providers & Services industry median of 2.59. Ultragreen Ai's overall GF Score™ is 31/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Return-on-Tangible-Asset calculated?
Return-on-Tangible-Asset is calculated from a company's financial statements. For Ultragreen Ai (FRA:U5T), the current Return-on-Tangible-Asset is 27.66% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Ultragreen Ai Ltd is engaged in the sales of Indocyanine Green (ICG) pharmaceutical products and cardiology Picture Archiving and Communication System (PACS) software and associated products and services. It provides a fluorescence imaging ecosystem designed to support surgeons with real-time perfusion data and visualization capabilities. The company is organised into business units based on its products and services and operates in (a) the Diagnostic Green (DxG) - Americas segment; (b) the DxG - Rest of the World segment; and (c) the UltraLinQ segment. The company generates the maximum of its revenue from the the DxG - Rest of the World segment, which focuses on the sales of ICG vials and related pharmaceutical products.
31GF Score
Get the complete analysis for FRA:U5T
Return-on-Tangible-Asset is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:U5T has been successfully added to your 
